Healthcare Equipment and Supplies
Company Overview of Transport Pharmaceuticals, Inc.
Transport Pharmaceuticals, Inc. develops drug/device combination products for the treatment of dermal diseases. The company offers SoloVir electrokinetic transdermal system (ETS) for the treatment of herpes labialis or cold sores; transungual ETS for the treatment of onychomycosis; steroid delivery ETS for the treatment of mild to moderate adult acne and psoriasis; and ETS imiquimod for actinic keratosis treatment. Transport Pharmaceuticals, Inc. was founded in 1999 and is based in Framingham, Massachusetts.
161 Worcester Road
Framingham, MA 01701
Founded in 1999
Key Executives for Transport Pharmaceuticals, Inc.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Transport Pharmaceuticals, Inc., please visit www.transportpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.